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A “HFPK3” peptide containing the 23 residues of the human immunodeficiency virus (HIV) fusion peptide (HFP) plus three non-native C-
terminal lysines was studied in dodecylphosphocholine (DPC) micelles with 2D 1H NMR spectroscopy. The HFP is at the N-terminus of the gp41
fusion protein and plays an important role in fusing viral and target cell membranes which is a critical step in viral infection. Unlike HFP, HFPK3
is monomeric in detergent-free buffered aqueous solution which may be a useful property for functional and structural studies. Hα chemical shifts
indicated that DPC-associated HFPK3 was predominantly helical from I4 to L12. In addition to the highest-intensity crosspeaks used for the first
chemical shift assignment (denoted I), there were additional crosspeaks whose intensities were ∼10% of those used for assignment I. A second
assignment (II) for residues G5 to L12 as well as a few other residues was derived from these lower-intensity crosspeaks. Relative to the I shifts,
the II shifts were different by 0.01–0.23 ppm with the largest differences observed for HN. Comparison of the shifts of DPC-associated HFPK3
with those of detergent-associated HFP and HFP derivatives provided information about peptide structures and locations in micelles.
© 2007 Elsevier B.V. All rights reserved.Keywords: DPC; Fusion peptide; HIV; NMR; Structural heterogeneity; Cryoprobe; SDS1. Introduction
The HIV gp41 protein catalyzes fusion between viral and
host cell membranes and contains an N-terminal fusion peptide
(HFP) of ∼20 residues which plays an essential role in fusion
[1–3]. Peptides containing the HFP sequence fuse unilamellar
lipid vesicles, and there is a good correlation between the
mutation/fusion activity relationships of HFP-induced vesicleAbbreviations: COSY, correlation spectroscopy; DPC, dodecylphosphocho-
line; DQ-COSY, double-quantum filtered correlation spectroscopy; DSS, 3-
(trimethylsilyl)-1-propanesulfonic acid, sodium salt; HEPES, N-(2-hydro-
xyethyl)piperazine-N′-2-ethanesulfonic acid; HFP, HIV fusion peptide;
HFPK3, HIV fusion peptide plus three lysines; HFPK3W, HIV fusion peptide
plus three lysines and a tryptophan; HIV, human immunodeficiency virus;
NMR, nuclear magnetic resonance; NOESY, nuclear Overhauser effect
spectroscopy; SDS, sodium dodecyl sulfate; TOCSY, total correlation
spectroscopy; WET, water suppression enhanced through T1 effects; 2D, two-
dimensional
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doi:10.1016/j.bbamem.2007.07.028fusion and gp41-catalyzed membrane fusion [4–10]. The HFP
is therefore thought to be a useful model fusion system.
This paper considers a HFP derivative in dodecylpho-
sphocholine (DPC) micelles. The micelles serve as a membrane
mimetic with which membrane-associated peptides can be
studied by liquid-state NMR. A perdeuterated DPC-d38 micelle
contains 50–60 detergent molecules with ∼20 kDa mass and
reorients rapidly in aqueous solution such that a large fraction of
the proton resonances of an associated peptide can be resolved
[11,12]. Because lipid molecules with phosphocholine head-
groups represent half of the total lipid in HIV host cell mem-
branes, DPC may be a reasonable detergent choice for HFP
studies [13,14]. DPC has also been used for NMR studies of
other peptides [15–20]. Observed structures include helices on
the micelle surface and helices which traverse the micelle.
Previous NMR and simulation studies of detergent-associ-
ated peptides containing the HFP sequence provided evidence
for helical structure over some of the residues but there were
differences among the studies about the specific helical regions
and about the location of the peptide in the micelle [21]. As one
Fig. 1. MALDI mass spectrum of HFPK3 with internal bovine insulin reference
(mass 5733 D). The experimental HFPK3 mass is 2511 D and the expected
HFPK3 mass is 2512 D.
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studied in sodium dodecyl sulfate (SDS) and DPC detergent
micelles [22–24]. In SDS, helical structure was reported from I4
to G16 followed by a β turn, while in DPC, helical structure was
reported from I4 to M19 with no β turn. For a SDS-associated
“HFP51” which contained residues 5–55 of gp41, helical
structure was detected from F8 to G13 and from V28 to Q41
[25]. For a SDS-associated “HFP30” which contained a non-
native proline followed by the first thirty residues of gp41 and
an eight-residue non-native polar sequence, an uninterrupted
helix was detected from I4 to M19 with some helical structure
from G20 to A22 [26]. The remaining residues were motionally
disordered. The HFP30 study was distinct in that the peptide
contained U-13C, 15N labeling and so in addition to Hα shifts
and NOEs, there were additional structural constraints from 13C
shifts and from 3JHNHα and residual dipolar couplings.
There has been some controversy about the location of the
HFP in micelles. Simulation studies have supported an amphi-
pathic helix on the micelle surface with more hydrophobic
sidechains in the micelle interior and less hydrophobic Ala and
Gly residues on the micelle surface [27,28]. However, there
were slow amide proton exchange rates with water protons for
residues between Ile-4 and Ala-15 which suggested that these
residues were not exposed to water and that their ∼18 Å length
may reside within the central∼30 Å diameter hydrophobic core
of the micelle [22,23,26,28,29].
For HFP in aqueous solution at pH 3, liquid-state NMR data
were consistent with predominantly unstructured peptide, while
in organic solvents, both helical and β strand conformations
have been observed [30,31]. Avariety of biophysical techniques
other than liquid-state NMR have been applied to study mem-
brane-associated HFP and show helical conformation as well as
β strand conformation which is associated with formation of
HFP oligomers or aggregates [1,32–35].
This paper investigates DPC-associated HFP derivatives
using 2D COSY, TOCSY, and NOESY spectra. There was
selective 13CO labeling in the peptide and 13C spectra were
recorded to obtain additional information. As part of the work, a
sensitivity comparison was made between spectra obtained with
a conventional probe and with a cryoprobe. The two HFP
derivatives are denoted HFPK3 (AVGIGALFLGFLGAAGST-
MGARSKKK) and HFPK3W (AVGIGALFLGFLGAAGSTM-
GARSKKKW) and contained 23 N-terminal residues of the
HIV gp41 fusion protein (LAV1a strain) and three non-native
lysines to increase aqueous solubility. For HFPK3W, there was
an additional non-native tryptophan for concentration determi-
nation using 280 nm absorbance.
HFPK3 and HFPK3W were studied in part because they are
monomeric in buffered neutral solution without detergent and
differ from HFP, which aggregates under these conditions [36].
These derivatives are thus reasonable model systems to study
membrane- or detergent-induced peptide self-association.
Lysine-containing HFPs have also been used to synthesize
C-terminal cross-linked HFPs which mimic the expected
topology of fusion peptides in the trimeric gp41 protein [37–
43]. These cross-linked HFPs induce vesicle fusion with a rate
which is 5–40 times higher than that of non-cross-linkedpeptides. One of the motivations for the present study was to
assess whether future studies on detergent-associated cross-
linked peptides can be done with unlabeled peptide or whether it
will be necessary to incorporate U–13C, 15N labeling.
2. Materials and methods
Peptides were synthesized as C-terminal amides on a solid-phase peptide
synthesizer (ABI, Foster City, CA) using FMOC chemistry and acetic anhydride
capping and were purified by reversed-phase HPLC. Fig. 1 displays a mass
spectrum of purified HFPK3 which indicated that any impurity peaks were b5%
of the main mass peak. HFPK3 contained selective 13CO labeling at F8, L9, and
G10, and HFPK3W contained a 13CO label at F8 and a 15N label at L9.
Sample preparation began with vortexing dry DPC-d38 (Avanti Polar Lipids,
Alabaster, AL) in 5 mM pH 7 HEPES-d18 buffer containing 0.2 mM
3-(trimethylsilyl)-1-propanesulfonic acid, sodium salt (DSS), 0.03% NaN3 pre-
servative, and 10%D2O. Lyophilized peptide was then dissolved in the detergent
solution and the pHwas adjusted to 7.0. Four samples were prepared: “sample 1”
contained∼2mMHFPK3Wand∼100mMDPC; “sample 2” contained∼2mM
HFPK3W and ∼200 mM DPC; “sample 3” contained ∼3 mM HFPK3 and
∼300 mM DPC; and “sample 4” was sample 3 with added DPC and contained
∼3 mM HFPK3 and ∼700 mM DPC.
AVarian Inova 600 MHz spectrometer with a conventional probe was used
to obtain DQ-COSY, TOCSY and NOESY spectra of sample 1, TOCSY and
NOESY spectra of sample 3, and a NOESY spectrum of sample 4. A Bruker
Avance-AQS 700 MHz spectrometer with a cryoprobe was used to obtain a
NOESY spectrum of sample 2. The sample temperatures were 40 °C. The
TOCSYmixing time was 90 ms. The NOESYpulse programs used on samples 1
and 2 were identical and contained in sequence: (1) z-gradient scrambling
(6 ms); (2) water presaturation (1.3 s); (3) π/2-pulse; (4) variable length time (t1);
(5) π/2-pulse; (6) longitudinal mixing time (τ) with a z-gradient pulse (5 ms) in
the middle of water saturation pulses; and (7) π/2-pulse initiated acquisition. At
600 MHz, π/2-pulses were 7.40 μs and 720 values of t1 were acquired with a
143 μs increment, τ was 70 or 150 ms, and 1024 complex t2 points were
acquired with a 125-μs increment. At 700 MHz, π/2-pulses were 12.45 μs, 720
values of t1 were sampled with 102 μs increment, τ was 70 ms, and 951 complex
t2 points were acquired with 102 μs increment. For the NOESY spectra of
samples 3 and 4, π/2-pulses were 6.44 μs, 800 values of t1 were sampled with
125 μs increment, τ was 150 ms, and 1024 complex t2 points were acquired with
a 125-μs increment. Effects of water were reduced by means of a WETsequence
during τ [44,45]. All NOESY spectra had 96 transients per t1 value, and scans
were summed with a 32-fold phase cycle.
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[46]. Data sets were zero-filled to produce 0.003 ppm/point digital resolution in
each dimension. In t2, the NOESY FIDs were Lorentzian narrowed by 20 Hz
and Gaussian broadened by 20 Hz while in t1 they were narrowed by 5 Hz and
broadened by 10 Hz and then modified with a sine+60° window. Third-order
polynomial baseline correction was applied in each dimension.
The 13C spectra of samples 3 and 4 were recorded on a 500-MHz Varian
UnityPlus spectrometer at 25 °C. The sequence used a 6 μs 76° 13C pulse, 1.3 s
acquisition of 35124 complex points with 1H decoupling, and a 5 s recycle delay.Fig. 2. NOESY spectra of HFPK3 in DPC micelles which were recorded at 600 MHz
using sample 3 ([HFPK3]=3 mm, [DPC]=300 mM) and spectra d–f were obtained u
samples are similar. In spectrum a, a set of paired arrows points to HN/HN crosspeaks
and G10′/F11′ (weaker intensity/assignment II). Another set of paired arrows poi
assignment I) and L9′/F8′ (weaker intensity/assignment II). Spectra c and f are slices t
assigned to Hα/HN crosspeaks of L9/G5 (9.01 ppm); L9/L9 (8.41 ppm); L9′/L9′ (8.
L12′/F11′ (7.92 ppm); L12′/L12′ (7.84 ppm).The spectrum of sample 3 was the sum of 12200 scans and was referenced to
DSS at 0 ppm.
The simulated annealing function of the CNS program was used to calculate
structures based on the intensities of unambiguous NOESY crosspeaks [47].
Internuclear distances were related to intensities using either the W27 sidechain
HN1–HC2 or the G5 Há1–Há2 crosspeaks.
A more detailed description of methods to obtain 1H NMR spectra, make 1H
chemical shift assignments, and derive peptide structure has been given in two
recent papers from the Veglia and Ramamoorthy groups [48,49].using a conventional probe and a 150 ms mixing time. Spectra a–c were obtained
sing sample 4 ([HFPK3]=3 mm, [DPC]=700 mM) and the spectra from the two
with f1≈8.2 ppm that are assigned to G10/F11 (stronger intensity/assignment I)
nts to peaks with f1≈8.4 ppm that are assigned to L9/F8 (stronger intensity/
hrough spectra b and e, respectively, at f1=3.99 ppm. The peaks in spectrum f are
35 ppm); L9/F8 (8.31 ppm); L9/G10 (8.18 ppm); L9/A6, F11, L12 (8.05 ppm);
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Fig. 2 displays sections of NOESY spectra of sample 3 and
sample 4 taken on a 600 MHz instrument with a conventional
probe. Both samples had [HFPK3]=3 mM and [DPC]=300
(sample 3) or 700 mM (sample 4). The spectra were similar
except that the chemical shifts of sample 4 were often
0.02–0.04 ppm lower than the analogous shifts of sample 3. A
chemical shift assignment (denoted I) is given in Table 1.
Shifts listed under assignment I corresponded to the most
intense crosspeaks in the NOESY spectrum of sample 3 except
for the shifts of the R, K, and W residues which were based on
the much stronger crosspeaks in the DQ-COSY spectrum of
sample 1 and the TOCSY spectrum of sample 3. J-splitting
was observed for the Hα of G3, G5, G13, and G16. For all but
five nuclei, the chemical shift variation among samples 1, 2,
and 3 was ≤0.02 ppm, and the variation for four of the
remaining five nuclei was 0.03–0.04 ppm. Only the L9 HN
shift varied more, ranging from 8.54 ppm in sample 1 toTable 1
Assignment I of DPC-associated HFPK3 (residues 1–26) and HFPK3W
(residue 27)
HN Hα Hβ Hγ Hδ Hε/Hring
Ala-1 4.14 1.51
Val-2 8.10 4.21 2.13 0.99
Gly-3 8.45 4.05, 4.08
4.16, 4.19
Ile-4 8.66 3.91 1.93 CH2: 1.31,
1.61
0.92
CH3: 0.95
Gly-5 9.04 3.72, 3.75
3.90, 3.93
Ala-6 8.06 4.12 1.47
Leu-7 7.96 4.11 1.62, 1.87 1.68 0.87,
0.91
Phe-8 8.36 4.33 3.23 7.11, 7.17, 7.21
Leu-9 8.45 4.00 1.60, 1.88 1.91 0.94,
0.95
Gly-10 8.20 3.91
Phe-11 8.08 4.41 3.23 7.11, 7.17, 7.21
Leu-12 8.09 3.87 1.50, 1.74 1.69 0.79,
1.19
Gly-13 8.10 3.84, 3.87
3.90, 3.93
Ala-14 7.87 4.30 1.45
Ala-15 8.25 4.09 1.29
Gly-16 8.36 3.84, 3.87
3.91, 3.93
Ser-17 8.02 4.41 3.94, 3.99
Thr-18 7.99 4.29 1.43
Met-19 8.11 4.38 2.08, 2.11 2.57, 2.63
Gly-20 8.26 3.94
Ala-21 8.02 4.27 1.25
Arg-22 8.12 4.30 1.82, 1.94 1.69 3.22
Ser-23 4.40 3.87, 3.91
Lys 7.89 4.14 1.80 1.40 1.69 3.00
Lys 7.87 4.32 1.87, 1.77 1.40 1.69 3.00
Lys 8.12 4.28 1.87, 1.81 1.40 1.69 3.00
Trp-27 8.05 4.29 3.21, 3.30 NH 10.43, 2H 7.28
4–7H 7.11, 7.45, 7.62
Fig. 3. Inter-residue NOE connectivities of assignment I shifts. Filled bars have
unambiguous assignment and hollow bars have ambiguous assignment. Peak
intensity is indicated by line thickness. The “SX” designation refers to any
connectivity other than HN–HN or Hα–HN connectivity. Most SX connectivities
were between sidechain protons of the two residues. The displayed
connectivities were observed for sample 3 and a similar pattern was observed
for sample 4. Subsets of these connectivities were observed in the spectra of
sample 1 and sample 2.8.45 ppm in sample 3. Shifts were constant for a given sample
for at least 1 month.
There were minimal or no inter-residue NOE connectivities
for the shifts of A1, T18, W27, and the three lysines, and the
shifts were primarily assigned by similarity to characteristic
shifts for these residues.
Relative to the 70 ms NOESY spectrum of HFPK3W
(sample 1) at 600 MHz without cryoprobe, there was on average
2.0 times higher signal-to-noise in the 700 MHz spectrum of
sample 2 with cryoprobe. An improvement of ∼ (7/6)3/2 ∼1.25
might be expected from the difference in magnetic fields. The
improvement varied among different regions of the spectra with
an average improvement of 1.8 in the HN/HN region and 2.5 in
the Hβ/HN region. Relative to the 600 MHz NOESY spectrum
of sample 1 with τ=70 ms, only three new crosspeaks were
observed in the 600 MHz spectrum of sample 1 with τ=150 ms,
and these new crosspeaks were also observed in the 700 MHz
spectrum of sample 2 with τ=70 ms.
The largest number of NOE crosspeaks was observed in the
spectra of samples 3 and 4 which contained the highest peptide
Fig. 4. Secondary chemical shifts in ppm units. With cases of two Hα or two Hβ
shifts, the line for each secondary shift is drawn with half-width. Unassigned
nuclei are denoted by the × symbol. Blank space at a given nucleus denotes
either a nucleus that does not exist (e.g. Gly Hβ) or zero difference from the
random coil shift. As noted in Table 1, there is ambiguity in the assignment of
individual sets of lysine crosspeaks to specific lysine residues. In this figure, the
secondary shifts for the lysine residues have the order given in Table 1.
Fig. 5. Inter-residue NOE connectivities of assignment II. Hα/HN and Hβ/HN
connectivities are denoted as arrows with the Hα or Hβ residue at the base of the
arrow and the HN residue at the point of the arrow. Connectivities with
unambiguous assignment are denoted as solid lines, and connectivities with
ambiguous assignment are denoted as dotted lines.
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The NOE connectivities are graphically displayed in Fig. 3. A
subset of these connectivities was observed in the spectra of
sample 1 and sample 2.Table 2
Assignments II and III of DPC-associated HFPK3
HN Hα Hβ Hγ Hδ
Assignment II
Ala-1 8.17 4.25 1.36
Gly-5 9.02
Ala-6 8.04 3.89 1.45
Leu-7 7.92 4.09 1.60, 1.85 1.66 0.86, 0.90
Phe-8 8.28 4.33 3.22
Leu-9 8.39 4.00 1.55, 1.85 1.91 0.92
Gly-10 8.15 3.89
Phe-11 7.94 4.44 3.22
Leu-12 7.86 3.98 1.55 0.82
Ala-14 7.82 4.32 1.42
Met-19 2.19 2.92, 2.98
Met-19 2.31 2.93, 2.99
Ala-21 4.32 1.23
Ser 7.76 4.52 3.90, 3.94
Assignment III
Leu-7 7.94
Phe-8 8.30 4.33 3.22
Leu-9 8.41Fig. 4 displays the secondary shift differences between
assignment I peaks in Table 1 and random coil shifts and the
generally negative Hα and HN secondary shifts indicate helical
structure [50,51]. A TALOS program comparison of sequential
triplets of experimental Hα chemical shifts with shifts from a
database of assigned proteins of known structure yielded right-
handed helical conformation for V2, G5-A15 and G20-R22
[52]. Beta or diverse conformations were predicted for G3, I4,
and G16, and no predictions were made for other residues
because of lack of assignment certainty for the T18, K24, K25,
and K26 residues. Simulated annealing did not yield a well-
defined structure which was likely due to the small number of
unambiguous Δi≥3 backbone NOE connectivities.
In addition to the strongest crosspeaks used for assignment I
and the weaker crosspeaks due to longer range connectivities
within this assignment, there were additional weaker crosspeaks
in the spectra of all samples. Many of these crosspeaks appeared
to be due an alternate peptide structure as evidenced by NOE
connectivities between the shifts of these peaks and lack of
connectivities with the shifts of assignment I. Table 2 lists
“assignment II” for crosspeaks whose intensities were ∼10% of
those of assignment I and which had contiguous inter-residue
connectivities between G5 and L12 (cf. Fig. 5). For the otherFig. 6. Assignment II—assignment I chemical shift differences for residues
G5-L12.
Fig. 7. 13C spectrum of sample 3 which had 13CO labels at F8, L9, and G10.
3230 C.M. Gabrys, D.P. Weliky / Biochimica et Biophysica Acta 1768 (2007) 3225–3234residues, shifts were assigned by proximity to shifts in
assignment I or, for M19, by its characteristic crosspeak pattern.
Some of the crosspeaks which led to assignment II are high-
lighted in Fig. 2. Fig. 6 displays some of the shift differences
between the II and I assignments. The HN nuclei exhibited the
largest shift differences, which were all negative, while Hα
nuclei had both positive and negative differences. Sidechain
nuclei exhibited the smallest differences.
“Assignment III” was made for L7 to L9 and was based on
crosspeaks whose intensities were ∼5% of those of assignment
I and on three inter-residue NOE connectivities. HN chemical
shifts of assignment III were closer to those of assignment I than
were the HN shifts of assignment II. The combination of
assignments I, II, and III accounted for all of the significant
crosspeaks in the NMR spectra.
Sample 3 had 13CO labels at F8, L9, and G10, and Fig. 7
displays the CO region of the 13C spectrum of this sample. There
are three major peaks at 179.9, 177.1, and 176.2 ppm, which are
assigned to L9, F8, and G10, respectively. This assignment is
based on: (1) residue-type characteristic shifts; (2) the
∼177 ppm F8 13CO shift observed in the filtered solid-state
NMR spectrum of a frozen solution sample containing F8 13CO
and L9 15N-labeled HFPK3 (2 mM) and DPC (200 mM) at
−80 °C; and (3) the 180.45, 177.36, and 176.48 ppm L9, F8, and
G10 13CO shifts reported for SDS-associated HFP30 [26,36,51].
In Fig. 7, each of the F8 and L9 residues has a smaller peak
∼0.09 ppm upfield of the major peak and the G10 residue has
two smaller peaks ∼0.09 and 0.19 ppm upfield of the major
peak. The spectrum of sample 4 was similar except for an
additional small peak 0.19 ppm upfield of the main L9 peak.
There was general consistency between the minor:major
intensity ratios in the 13C spectra and the (assignment II+ III)/
(assignment I) intensity ratios in the 2D 1H spectra.
For samples 1–4, the peptide:DPC mol ratio was ≤0.02 and
corresponded to≤1 peptide/micelle. When a fifth sample was
made which contained peptide:DPC ∼0.1 (5 peptides/micelle),
the lines were broad (∼0.1 ppm full-width at half-maximum).
This broadening is consistent with peptide aggregation and with
detection of β structure in circular dichroism spectra at this
peptide:detergent ratio [53]. Sharp NMR signals (∼0.03 ppm)
could be recovered upon addition of DPC to achieve peptide:detergent ∼0.02 which suggests that aggregation is reversible
and that the aggregates contain a small number of peptide
molecules.
4. Discussion
The assignment I shifts of the first twelve residues exhibited
abundant backbone NOE connectivity with ten unambiguous
Δi=2 crosspeaks and six unambiguous Δi=3 crosspeaks. The
I4-L12 Hα shifts were all consistent with helical conformation
but the presence of both Δi=2 and Δi=3 backbone NOEs was
consistent with a variety of secondary structures and may pro-
vide some basis for why simulated annealing did not result in a
well-defined conformation [54]. There were many fewer
backbone NOEs for residues C-terminal of L12 which indicates
a higher degree of motion in the C-terminal part of the peptide.
In the COSY and TOCSY spectra, weaker intensities were
likewise observed for residues C-terminal of G16. These
observations support a model of more-defined structure in the
N-terminal region and less-defined structure in the C-terminal
region. This model is consistent with stronger interaction of the
apolar N-terminal region with the micelle and with weaker
interaction of the more polar C-terminal region with the micelle.
Relative to previous studies of detergent-associated HFP, the
smaller number of NOEs seen with HFPK3 and HFPK3W may
be due to the three non-native C-terminal lysines which inhibit
peptide aggregation in aqueous solution. These residues may
similarly solubilize the C-terminal segment of the DPC-
associated peptide and the increased motion may reduce NOE
intensity. The relatively sparse NOE data for HFPK3 suggest
that structure determination of detergent-associated lysine-rich
cross-linked HFPs will require U–13C, 15N labeling and
structural constraints other than NOEs.
It is interesting to compare backbone chemical shift assign-
ment I in Table 1 with the three previously published assign-
ments. When the same referencing is used for DPC-associated
HFPK3 and DPC-associated HFP, the HN shifts of residues G3-
R22 of the HFP sample are on average +0.12 ppm higher than
the corresponding shifts of the HFPK3 sample [24,55]. A similar
comparison of the Hα shifts yields HFP shifts which are
+0.05 ppm higher. The different average offsets for different
nuclei suggest that this is not a referencing problem. Because the
HFP and HFPK3 shifts are reported at 298 and 313 K, respect-
ively, there may be some temperature component to the offsets.
However, temperature dependences of shifts reported in the
literature would predict smaller offsets than those observed
between the HFP and HFPK3 assignments [56]. After the
+0.12 ppm and +0.05 ppm offsets are removed for HN and Hα,
the average magnitude of difference 〈|δHFP−δHFPK3|〉 between
the two assignments is 0.03 ppm.
Although the SDS-associated HFP and HFP30 shifts were
obtained at 293 and 298 K, respectively, there were no
systematic offsets between assignment I of residues L7-A21
and the corresponding assignments of the SDS-associated HFP
constructs. Comparison of assignment I and the assignment of
SDS-associated HFP yielded an average magnitude of differ-
ence for both HN and Hα shifts of 0.06 ppm while for the HFP30
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A6, the Hα shifts agreed to within 0.1 ppm among the three
assignments but the HN shifts of the SDS samples were
substantially smaller (up to 0.64 ppm) than the HN shifts of
assignment I. The HN assignment of the two SDS-associated
peptides agreed to within 0.1 ppm over this residue range. For
residue V2, there was a large variation among the three
assignments for both HN and Hα (up to 0.68 and 0.16 ppm,
respectively).
The chemical shift information may be related to structural
features. We first compare DPC-associated HFPK3 assignment
I with SDS-associated HFP30 because there are the greatest
structural data for the latter sample. For the two samples, there is
0.02 ppm average magnitude variation of the I4-A21 Hα shifts.
These shifts are sensitive to local conformation and the small
shift variation among the two samples is consistent with very
similar conformations over I4-A21, i.e. a single helix from I4-
M19 and some helical structure at G20 and A21. This structure
contrasts with the helix–turn–helix motif observed for the DPC-
associated influenza fusion peptide and demonstrates that there
is significant variation of helical structures of fusion peptides
from different viruses [18]. There is 0.05 ppm average
magnitude variation of L7-A21 HN shifts. These shifts are
sensitive to local conformation as well as hydrogen bonding and
the small shift variation among the two samples suggests that
the two samples have similar conformations as well as hydrogen
bond partners over these residues. These results also correlate
with the similar 1H/15N HSQC spectra obtained for HFP30 in
SDS and DPC [26].
For the G3-A6 HN shifts, there are differences as large as
0.64 ppm between the HFPK3 and HFP30 samples. This
observation may be explained by different hydrogen bonding
environments for these nuclei because they are at the N-
terminus of a helix. The G3-A6 HN shifts for SDS-associated
HFP and HFP30 agree to within 0.1 ppm and the G3-A6 HN
shifts for DPC-associated HFP and HFPK3 agree to within
0.1 ppm if the previously discussed 0.12 ppm offset is removed.
These data suggest a significant detergent effect on HN shifts in
this region. While all samples had pH ∼7, the SDS-associated
HFP30 and DPC-associated HFPK3 were buffered while the
SDS- and DPC-associated HFP samples were not buffered.
These data suggest that buffer does not play a large role in the
HN chemical shifts.
The chemical shift comparison also provides information
about fusion peptide location in micelles which relates to the
important question of peptide location in membranes. The
insertion angle and depth of the peptide are parameters which
are believed to relate to fusion peptide activity [8,57,58]. Two
models for the peptide location in the micelle are a surface-
associated amphipathic helix and a helix whose I4 to A15
region resides within the hydrophobic micellar interior
[22,23,26,28]. The similarity of the backbone shifts of SDS-
associated HFP30 and DPC-associated HFPK3 argues in favor
of the same micelle orientation for the two peptides. In
particular, the helical L7-A14 residues of SDS-associated
HFP30 are posited to be in the hydrophobic micelle interior
and there would likely be shift changes in our DPC-associatedHFPK3 sample if some of these residues were in the aqueous
headgroup region as would be expected for a surface
orientation. It is possible that the systematic shift difference
between DPC-associated HFP and DPC-associated HFPK3 is
partially due to different locations in the micelle. We note that
there have been conflicting results about HFP location in
membranes in other experimental and computational studies
[8,59–61].
As discussed above, the G3-A6 HN are likely not part of
intra-peptide hydrogen bonds and their shifts are thus more
sensitive to the local environment. The G3-A6 HN shifts are
different for DPC- and SDS-associated peptides and could
reasonably be correlated to the location of these residues near
the different headgroups of the two detergents. This result is
consistent with other data in the HFP30 study [26].
A distinguishing feature of the current fusion peptide study is
the observation of additional crosspeaks which led to assign-
ments II and III. There were inter-residue NOE connectivities
between assignment I shifts, between assignment II shifts, and
between assignment III shifts, but there are no connectivities
between shifts from different assignments. This observation
suggests that there are three distinct peptide species.
It is noted that alternate crosspeaks and assignments have
been observed for other peptides associated with detergent or
membranes [62–65]. In some studies, it was observed that
increased detergent concentration resulted in smaller ratios of
alternate to primary crosspeak intensities [66–68]. However, in
the present study, assignment II:assignment I ratios of ∼0.1
were observed for [HFPK3]=3 mM and either [DPC]=300 mM
(sample 3) or [DPC]=700 mM (sample 4) as well as for
[HFPK3W] = 2 mM, [DPC] = 100 mM (sample 1) or
[HFPK3W]=2 mM, [DPC]=200 mM (sample 2). The
assignment II crosspeaks of DPC-associated HFPK3 are
probably also too large to be ascribed to a peptide impurity
(cf. Fig. 1). Sample degradation is another possibility but seems
unlikely because: (1) the samples contained 0.03% NaN3
preservative; (2) the assignment II/assignment I crosspeak
intensity ratio of ∼0.1 was observed for several samples; and
(3) assignment II shifts were observed across the length of the
peptide. Assignment II could be due to a peptide population
with oxidized M19, but NMR studies of other peptides have
shown that methionine oxidation only affects shifts of nearby
residues [69,70]. The crosspeaks might also be due to peptide
not bound to DPC but this seems unlikely because [unbound
HFPK3]/[bound HFPK3] ∼0.001 as calculated using [HFPK3],
[DPC], and the published HFP/DPC association constant [24].
In addition, unbound HFPK3 likely has a different conforma-
tion than DPC-associated HFPK3 with corresponding large
changes in chemical shifts [22,30]. By contrast, the differences
between assignment I and II shifts are ∼0.05 ppm with larger
differences for HN than for Hα. Differences of this order-of-
magnitude could be associated with different helical curvatures
for the assignment I and II species [71]. Alternatively, the two
species could have different micelle locations. It is intriguing
that the shift differences in Fig. 6 oscillate with the approximate
period of an α helix. This might be expected when comparing
the residues of a peptide which traverses the micelle and those
3232 C.M. Gabrys, D.P. Weliky / Biochimica et Biophysica Acta 1768 (2007) 3225–3234of a peptide on the micelle surface. In the former species, all
residues would be in the hydrophobic micellar interior, while in
the latter species, there could be α helical alternation of residues
between the hydrophobic interior and the aqueous headgroup
region. Crosspeaks were not observed between the shifts of
different assignments which suggests that the characteristic
exchange times between the species are longer than the NOESY
exchange times of ∼100 ms.
The line broadening observed with high HFPK3:DPC ratio
may be due to formation of aggregates and recovery of sharp
signals with detergent addition may reflect conversion to helical
monomers. The reversibility suggests that the aggregates are
small which correlates with: (1) the trimeric association state of
gp41; (2) data on small aggregate size in membrane-associated
HFPs; and (3) functional and modeling studies suggesting that
fusion is most efficiently mediated by small fusion protein and
fusion peptide aggregates [10,36,72–74].
In summary, 1H chemical shift assignment of the DPC-
associated HFPK3 fusion peptide derivative yielded chemical
shifts similar to those of other detergent-associated fusion
peptide derivatives and were particularly close to those of the
SDS-associated HFP30 peptide. This similarity suggests
comparable helical conformation and micelle location for the
two peptides. The main shift differences between the two
peptides occurred for G3-A6 HN and are consistent with the
proximity of these nuclei to the micellar headgroup region. In
addition to the assignment I shifts corresponding to the most
intense peaks in the spectra, there was a set of assignment II
shifts which corresponded to less intense peaks. The magni-
tudes of the differences between assignment II and assignment I
shifts were typically 0.05 ppm and HN exhibited the largest
differences. The two assignments may correspond to different
peptide helical curvatures or to different peptide locations in the
micelle.
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